Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET)
- 31 May 2016
- journal article
- research article
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 30 (8) , 588-592
Abstract
Objective To evaluate the prognostic role of the ratio between target lesion and liver SUVmax (rPET) in patients with Hodgkin lymphoma (HL) undergoing interim FDG-PET/CT and to compare rPET with the 5-point Deauville Score (5p-DS). Methods Sixty-eight patients with HL undergoing interim FDG-PET/CT after first courses of chemotherapy were evaluated. The receiver operating characteristic (ROC) approach was applied to identify the optimal cutpoint of rPET with respect to progression free survival (PFS). The prognostic significance of rPET was compared with 5p-DS (scores 4 and 5 considered as positive). Positive predictive value (PPV) and negative predictive value (NPV) were calculated using the presence of an adverse event as the gold standard. Results The ROC analysis for rPET as a predictor of progression showed an optimal rPET cutpoint of 1.14. Both 5p-DS and rPET were strong outcome predictors (p < 0.001). Patients with negative 5p-DS and patients with rPET 1.14 had a 2-year PFS of 15 %. 5p-DS and rPET cutoff of 1.14 showed a PPV of 58 versus 70 %, and a NPV of 85 versus 86 %, respectively. Conclusions rPET could be considered an accurate prognostic factor in patients with HL undergoing interim FDG-PET/CT. Larger prospective studies are needed to confirm these data.Keywords
This publication has 14 references indexed in Scilit:
- Prognostic value of interim FDG‐PET in Hodgkin lymphoma: systematic review and meta‐analysisBritish Journal of Haematology, 2015
- FDG PET/CT imaging as a biomarker in lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2015
- The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage diseaseBlood, 2014
- FDG PET/CT methodology for evaluation of treatment response in lymphoma: from “graded visual analysis” and “semiquantitative SUVmax” to global disease burden assessmentEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 TrialJournal of Clinical Oncology, 2014
- The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scaleHaematologica, 2014
- qPET – a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Interim 18F-FDG PET SUVmax Reduction Is Superior to Visual Analysis in Predicting Outcome Early in Hodgkin Lymphoma PatientsJournal of Nuclear Medicine, 2014
- Interim-treatment quantitative PET parameters predict progression and death among patients with hodgkin's diseaseRadiation Oncology, 2012
- A Systematic Review of the Factors Affecting Accuracy of SUV MeasurementsAmerican Journal of Roentgenology, 2010